Accordingly, the knockdown of lncRNA H19 resulted in miR-29a upregulation and the downregulation of its target, vasohibin 2 (VASH2), in ECs, ultimately leading to the inhibition of glioma-induced EC angiogenesis in vitro [73]. Here, VASH2 is linked to central nervous system cancer.